Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

Sight Sciences (SGHT) 10K Form and Latest SEC Filings 2026

Sight Sciences logo
$5.13 +0.27 (+5.56%)
As of 02:50 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Latest Sight Sciences SEC Filings & Recent Activity

Sight Sciences (NASDAQ:SGHT) has submitted 330+ documents to the U.S. Securities and Exchange Commission (SEC) since 2018. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. The most recent filing was a Form 4 submitted on May 19, 2026.

Form 4
Sight Sciences, Inc. Reports Ownership Change on May. 19, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
Sight Sciences Files Current Report on Apr. 23, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
Sight Sciences Files Quarterly Report on May. 6, 2026

The 10-Q contains Sight Sciences's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

Sight Sciences SEC Filing History

Browse Sight Sciences' complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
05/19/2026 3:42 PM
Bauerlein Alison (1596080) Reporting
Sight Sciences (1531177) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2026 2:35 PM
Bauerlein Alison (1596080) Reporting
Sight Sciences (1531177) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/06/2026 3:30 PM
Sight Sciences (1531177) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/23/2026 7:01 AM
Sight Sciences (1531177) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2026 3:37 PM
Sight Sciences (1531177) Filer
Form DEFA14A
04/22/2026 3:36 PM
Sight Sciences (1531177) Filer
Form DEF 14A
04/09/2026 4:16 PM
HAYDEN JEREMY B. (1650737) Reporting
Sight Sciences (1531177) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2026 4:17 PM
Rodberg James (1961970) Reporting
Sight Sciences (1531177) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2026 12:48 PM
KCK LTD. (1657662) Filed by
Sight Sciences (1531177) Subject
Form SCHEDULE 13G/A
04/06/2026 3:09 PM
HAYDEN JEREMY B. (1650737) Reporting
Sight Sciences (1531177) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/06/2026 3:16 PM
Rodberg James (1961970) Reporting
Sight Sciences (1531177) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/03/2026 3:27 PM
Badawi Paul (1870865) Reporting
Sight Sciences (1531177) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2026 3:27 PM
Sight Sciences (1531177) Issuer
Taylor Brenton (1596103) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2026 3:28 PM
Badawi David (1870825) Reporting
Sight Sciences (1531177) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2026 3:28 PM
Bauerlein Alison (1596080) Reporting
Sight Sciences (1531177) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2026 2:18 PM
Badawi Paul (1870865) Reporting
Sight Sciences (1531177) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/01/2026 2:12 PM
Sight Sciences (1531177) Subject
Taylor Brenton (1596103) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/30/2026 6:07 AM
Sight Sciences (1531177) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2026 3:19 PM
Sight Sciences (1531177) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/05/2026 3:47 PM
Sight Sciences (1531177) Issuer
Taylor Brenton (1596103) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2026 3:48 PM
Rodberg James (1961970) Reporting
Sight Sciences (1531177) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2026 3:48 PM
Badawi Paul (1870865) Reporting
Sight Sciences (1531177) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2026 3:48 PM
Bauerlein Alison (1596080) Reporting
Sight Sciences (1531177) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2026 3:49 PM
HAYDEN JEREMY B. (1650737) Reporting
Sight Sciences (1531177) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2026 3:49 PM
Badawi David (1870825) Reporting
Sight Sciences (1531177) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2026 11:09 AM
KCK LTD. (1657662) Filed by
Sight Sciences (1531177) Subject
Form SCHEDULE 13G/A
02/03/2026 4:30 PM
Sight Sciences (1531177) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2026 3:54 PM
Badawi Paul (1870865) Reporting
Sight Sciences (1531177) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2026 3:55 PM
Rodberg James (1961970) Reporting
Sight Sciences (1531177) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2026 3:56 PM
Badawi David (1870825) Reporting
Sight Sciences (1531177) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2026 2:29 PM
Rogers Erica J. (1769940) Reporting
Sight Sciences (1531177) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2026 6:09 AM
Sight Sciences (1531177) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/12/2026 3:06 PM
Rogers Erica J. (1769940) Reporting
Sight Sciences (1531177) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/06/2026 6:01 PM
Sight Sciences (1531177) Issuer
Taylor Brenton (1596103) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2026 6:03 PM
Bauerlein Alison (1596080) Reporting
Sight Sciences (1531177) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2026 6:04 PM
Rodberg James (1961970) Reporting
Sight Sciences (1531177) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2026 6:08 PM
Badawi David (1870825) Reporting
Sight Sciences (1531177) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2026 6:09 PM
HAYDEN JEREMY B. (1650737) Reporting
Sight Sciences (1531177) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2026 6:10 PM
Badawi Paul (1870865) Reporting
Sight Sciences (1531177) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2026 3:19 PM
Bauerlein Alison (1596080) Reporting
Sight Sciences (1531177) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/02/2026 3:13 PM
Badawi David (1870825) Reporting
Sight Sciences (1531177) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Your $29.97 book is free today (Ad)

Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.tc pixel

Normally $29.97. Today it's free. Grab your copy now.
01/02/2026 3:21 PM
Badawi Paul (1870865) Reporting
Sight Sciences (1531177) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/30/2025 3:11 PM
Badawi David (1870825) Reporting
Sight Sciences (1531177) Issuer
Form 4/A
12/30/2025 3:11 PM
Badawi David (1870825) Reporting
Sight Sciences (1531177) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2025 3:12 PM
Rogers Erica J. (1769940) Reporting
Sight Sciences (1531177) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/29/2025 1:48 PM
Rogers Erica J. (1769940) Reporting
Sight Sciences (1531177) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/18/2025 5:10 PM
Encrantz Staffan (1870875) Reporting
Sight Sciences (1531177) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2025 3:19 PM
Rodberg James (1961970) Reporting
Sight Sciences (1531177) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2025 3:39 PM
Rodberg James (1961970) Reporting
Sight Sciences (1531177) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2025 5:52 PM
HAYDEN JEREMY B. (1650737) Reporting
Sight Sciences (1531177) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2025 2:45 PM
Link Matthew (1565950) Reporting
Sight Sciences (1531177) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/25/2025 3:53 PM
HAYDEN JEREMY B. (1650737) Reporting
Sight Sciences (1531177) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/25/2025 3:43 PM
Link Matthew (1565950) Reporting
Sight Sciences (1531177) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/24/2025 3:45 PM
Link Matthew (1565950) Reporting
Sight Sciences (1531177) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2025 3:58 PM
Link Matthew (1565950) Reporting
Sight Sciences (1531177) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/20/2025 3:16 PM
Link Matthew (1565950) Reporting
Sight Sciences (1531177) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/18/2025 4:24 PM
Sight Sciences (1531177) Issuer
Taylor Brenton (1596103) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2025 3:19 PM
Link Matthew (1565950) Reporting
Sight Sciences (1531177) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/17/2025 3:05 PM
Sight Sciences (1531177) Subject
Taylor Brenton (1596103) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2025 6:48 PM
HAYDEN JEREMY B. (1650737) Reporting
Sight Sciences (1531177) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2025 3:08 PM
Link Matthew (1565950) Reporting
Sight Sciences (1531177) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/12/2025 7:11 AM
Link Matthew (1565950) Reporting
Sight Sciences (1531177) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2025 3:31 PM
Rodberg James (1961970) Reporting
Sight Sciences (1531177) Issuer
Form 3
Initial statement of beneficial ownership of securities  
11/06/2025 3:19 PM
Sight Sciences (1531177) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2025 3:11 PM
Sight Sciences (1531177) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2025 2:13 PM
Link Matthew (1565950) Reporting
Sight Sciences (1531177) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/17/2025 2:36 PM
Link Matthew (1565950) Reporting
Sight Sciences (1531177) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/17/2025 6:05 AM
Sight Sciences (1531177) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/08/2025 7:12 PM
Sight Sciences (1531177) Issuer
Taylor Brenton (1596103) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2025 3:28 PM
Sight Sciences (1531177) Subject
Taylor Brenton (1596103) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2025 4:52 PM
HAYDEN JEREMY B. (1650737) Reporting
Sight Sciences (1531177) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2025 4:53 PM
Badawi David (1870825) Reporting
Sight Sciences (1531177) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2025 4:53 PM
Badawi Paul (1870865) Reporting
Sight Sciences (1531177) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2025 4:53 PM
Bauerlein Alison (1596080) Reporting
Sight Sciences (1531177) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2025 3:47 PM
Badawi David (1870825) Reporting
Sight Sciences (1531177) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2025 3:25 PM
Link Matthew (1565950) Reporting
Sight Sciences (1531177) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2025 3:26 PM
HAYDEN JEREMY B. (1650737) Reporting
Sight Sciences (1531177) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2025 2:52 PM
Bauerlein Alison (1596080) Reporting
Sight Sciences (1531177) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/01/2025 3:17 PM
Badawi Paul (1870865) Reporting
Sight Sciences (1531177) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/23/2025 3:38 PM
Link Matthew (1565950) Reporting
Sight Sciences (1531177) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/19/2025 9:01 AM
Link Matthew (1565950) Reporting
Sight Sciences (1531177) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2025 2:30 PM
Link Matthew (1565950) Reporting
Sight Sciences (1531177) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/15/2025 4:28 PM
Mazzacco Catherine (1967722) Reporting
Sight Sciences (1531177) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2025 3:18 PM
Link Matthew (1565950) Reporting
Sight Sciences (1531177) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/03/2025 3:23 PM
Sight Sciences (1531177) Issuer
Taylor Brenton (1596103) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2025 5:36 PM
Badawi David (1870825) Reporting
Sight Sciences (1531177) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2025 8:24 PM
Link Matthew (1565950) Reporting
Sight Sciences (1531177) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2025 8:25 PM
Badawi David (1870825) Reporting
Sight Sciences (1531177) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2025 8:27 PM
Badawi Paul (1870865) Reporting
Sight Sciences (1531177) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2025 8:27 PM
Bauerlein Alison (1596080) Reporting
Sight Sciences (1531177) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2025 8:32 PM
HAYDEN JEREMY B. (1650737) Reporting
Sight Sciences (1531177) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
The REAL Reason Trump is Invading Iran (Ad)

For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel

Click here to find out what it is.
07/03/2025 2:13 PM
Badawi David (1870825) Reporting
Sight Sciences (1531177) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/03/2025 2:05 PM
HAYDEN JEREMY B. (1650737) Reporting
Sight Sciences (1531177) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/02/2025 3:45 PM
Link Matthew (1565950) Reporting
Sight Sciences (1531177) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/01/2025 3:27 PM
Badawi Paul (1870865) Reporting
Sight Sciences (1531177) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/10/2025 8:32 PM
Mazzacco Catherine (1967722) Reporting
Sight Sciences (1531177) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025 8:53 PM
Fountain Tamara (1902243) Reporting
Sight Sciences (1531177) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025 8:54 PM
Rogers Erica J. (1769940) Reporting
Sight Sciences (1531177) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025 8:54 PM
Larsen-Becker Brenda Jane (1913647) Reporting
Sight Sciences (1531177) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025 8:53 PM
Sight Sciences (1531177) Issuer
Zurbay Donald (1341608) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Sight Sciences SEC Filings - Frequently Asked Questions

Sight Sciences (SGHT) has submitted 330+ filings to the SEC since 2018. You can browse the complete history or filter by form type using the tools above.

Sight Sciences's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results.

The most recent filing was a Form 4 submitted on May 19, 2026. This was an insider ownership change filed by 4 - Sight Sciences, Inc. (0001531177) (Issuer).

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:SGHT) was last updated on 5/21/2026 by MarketBeat.com Staff.
From Our Partners